Professional Marketing briefs
Lilly announced that it will eliminate around 300 positions in its US diabetes, neuroscience and osteoporosis sales forces as it introduces a new sales model featuring smaller territories manned by a rep with greater therapeutic expertise. The new sales model will replace large territories with multiple sales partners. Part of Lilly's strategy is to help reps better connect with physicians and increase accountability.
Zogenix will co-promote Sumavel DosePro (sumatriptan injection) needle-free delivery system with Astellas Pharma US. Sumavel DosePro which received FDA approval in July 2009, is a first-of-its-kind needle-free delivery system for subcutaneous sumatriptan, a treatment that provides migraine relief within 10 minutes for some patients.